London, UK, 1 February 2007: BioProgress plc ('BioProgress' or the 'Company')
(AIM: BPRG; NASDAQ: BPRG), the speciality pharmaceutical and healthcare company,
today announces the creation of a new executive operational board for the
Company, and the appointment of Keith Hemming, as Head of Operations, a new
position within the management team of BioProgress.
